Clinical trial
Precision Medicine Offers Belatacept Monotherapy (PROBE)
NCT02939365 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Precision Medicine Offers Belatacept Monotherapy (PROBE)
- Lead sponsor
- University of California, San Francisco
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- February 28, 2019
- Completion date
- December 31, 2022
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
transplantation